Related Experiment Video
Updated: Aug 14, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Surveillance for the Rare Condition of Sickle Cell Disease in Wisconsin
Ashima Singh1, Mahua Dasgupta2, Dawn Retherford2
1Department of Pediatrics, Section of Hematology/Oncology/Bone Marrow Transplantation, Medical College of Wisconsin, Milwaukee, Wisconsin, ashimasingh@mcw.edu.
Introduction:
Despite universal newborn screening, there is no comprehensive surveillance system to understand the sickle cell disease population in Wisconsin.
Methods:
We initiated the development of a sickle cell disease surveillance system by linking newborn screening data and electronic health records from 2 large tertiary health care institutions in Wisconsin: Children's Wisconsin and Froedtert Hospital.
Results:
There were 1478 individuals within the 3 data sources. One hundred thirty-two (82%) of 159 identified by newborn screening from 2013 through 2019 received care at Children's Wisconsin. The majority of individuals with sickle cell disease at Children's Wisconsin and Froedtert Hospital resided in Milwaukee County.
Discussion:
The new surveillance program will increase our understanding of the sickle cell disease population in Wisconsin and help improve quality of care and health outcomes.
Related Concept Videos
Principles of Disease Surveillance
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

